Home » Healthcare » Pharmaceuticals » Antihistamines Market

Antihistamines Market By Type (Prescription-based, Over-the-counter (OTC))) By Indication (Urticaria, Allergy, Dermatitis, Others) By Dosage form (Tablets, Capsules, Others) By Route of Administration (Oral, Parenteral, Others) By End-Users (Tablets, Hospitals, Specialty Clinics, Homecare, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Hospitals, Others) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2028

Name: Antihistamines Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2022-07-14
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Antihistamines Market

Summary
Table Of Content
Request Sample

What is the Key Indication Diseases of Antihistamines?

Asthma and Allergic patients are increasing on a daily basis due to the air pollution. The prevalence of allergic rhinitis (A.R.) has increased dramatically over the past three decades, according to the American College of Allergy, Asthma, and Immunology (ACAAI). More than 40% of people in the U.S. and Europe are sensitive to one or more inhalant allergies. Intensifying air pollution and higher allergen sensitivity may be contributing factors to the rising prevalence of A.R. Antihistamines are useful as they address the particular cell receptors designed for histamines. Antihistamines are a class of medications that block the effects of histamine. Histamine is an immunological substance that the body’s immune system releases in reaction to an allergen attack or when histamine-deficient foods are consumed. Some foods also cause an excessive amount of histamine to be produced, which results in an allergic response.

What is the Market Size of Antihistamines in term of value?

Global Antihistamines Market is projected to increase at a significant CAGR of 9.50% in the coming years. In 2021, the global Antihistamines market was valued at USD 215.9 Million and is projected to reach the value of USD 371.2 million by 2028. The demand for Antihistamines is projected to increase substantially in the coming years. It is presumed to generate revenue opportunities for the key industry players worth USD 156.26 million during the forecast period between 2022 and 2028.

Which is Major Manufacture Country for Antihistamines ?

The market share for Antihistamines in North America is the largest in the United States in 2021. The dominance is brought about by an increase in allergic rhinitis cases among children. The prevalence of allergic rhinitis among children was predicted to be around 21.1% in the year 2020. In addition, sales of nasal Antihistamines will be driven higher over the evaluation period by the rising use of nasal sprays as well as the U.S.’s well-established healthcare system.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Interesting Facts about Antihistamines Industry

The top 5 countries for Antihistamines exports are the United States, India, China, the United Kingdom, and Germany.
The top 5 importers of Antihistamines are Australia, Chile, France, Israel, and Singapore.
Due to rising disposable income and shifting Route of Administration lifestyles, the market for antihistamine drugs will expand. The aging population’s expansion will also enhance the market’s growth rate and the creation of cutting-edge drug solutions for treating allergic diseases are the major factors driving the market’s growth.
However, the advent of generic medications and the expiration of proprietary medications may slow the market’s expansion. The market for antihistamine medications will face challenges due to the absence of healthcare infrastructure in developing economies, and high implementation costs are projected to hinder the growth of the Antihistamines market over the forecast period.
North America region had a major share in terms of volume and value in the global Antihistamines market in 2021 and is projected to continue its dominance over the forecast period.
Hospitals to witness high growth during the forecast period due to increased awareness for organic products among end users across the globe.

Who are the Top 10 players/companies in Antihistamines market in term of value and volume?

The key players in the global Antihistamines market in terms of value and volume include Akorn, Incorporated (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Glenmark Pharma (India), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France). In order to increase their production of Antihistamines and capture a competitive market share on a global scale, these leading companies are focusing on new product advancements as well as technological innovation. Additionally, several regional and national players are investing significantly to diversify their product offerings and increase sales. For instance, in May 2021, In India, Glenmark Pharma introduced Ryaltris, a nasal spray. One of the global leaders in the respiratory sector, Glenmark was the first to release the branded version in India at a competitive price. On the other hand ,in June 2021, Through a procedure known as a partial prescription to nonprescription transition, the FDA approved the use of Bayer AG’s Astepro, which is used to treat seasonal and perineal allergies, for nonprescription usage. Due to the FDA’s approval, people can now acquire a safe and efficient nasal antihistamine without the help of a healthcare professional.

Who are the Top 10 Countries in the Antihistamines Market?

The major countries in the global Antihistamines market are China, India, the U.S., Canada, the U.K., Germany, France, Brazil, Japan, South Korea, and Italy. Due to the high cost of Antihistamines there as well as the rising trend of self-medication, North America is anticipated to account for a sizable portion of the global market over the forecast period. Additionally, it is predicted that the market for Antihistamines would grow due to the high prevalence of allergy disorders in this area.

Which is the Key End User Area in the Antihistamines Market?

The key Dosage Forms of Antihistamines include (Hospitals, Specialty Clinics, Homecare, and Other. It is mostly used in Hospitals. Antihistamines are mostly used to treat allergic conditions’ symptoms, including itchiness, runny nose, stuffy nose, urticaria, tearful eyes, dizziness, coughing, and nausea. Sedation, reduced motor function, dry mouth and tongue, dizziness, blurred vision, constipation, and urine retention are a few of the side effects that are frequently reported after using Antihistamines. Antihistamines have several uses, including treating allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and other conditions (angioedema, pruritus, and others). Due to the largest global prevalence of disease along with increased awareness and accessibility linked to diagnosis and treatment of diseases, allergic rhinitis and urticaria jointly accounted for more than 50% of the market share in 2020.

What are the Major Driving Factors for Antihistamines Market?

The increasing incidence of allergic responses and allergies worldwide is a significant element fueling the market’s expansion for antihistamine medications. Antihistamines are used to treat seasonal allergies, motion sickness, nausea, cold and cough, and anxiety. They are also employed to treat urticaria, a skin allergy. The increase in healthcare spending, which helps to improve its infrastructure, is a crucial element influencing the growth rate of the antihistamine medicine market. The antihistamine medications market will also grow due to growing public and private activities to raise awareness about how to treat diverse allergic reactions. Additionally, the antihistamine medications market will grow due to increased disposable income and changing Route of Administration lifestyles. Along with this, the market’s growth rate will be accelerated by the growing elderly population and the development of novel medication therapies for the treatment of allergic illnesses.

What are the Major Restraints for Antihistamines Market?

The key restraint of the global Antihistamines market is that the patents will hamper the market’s growth rate on pharmaceuticals expiring and the release of generic versions. Furthermore, the market for antihistamine medications will face challenges due to the absence of healthcare infrastructure in developing economies and high implementation costs. Additionally, during the projected period of 2022–2029, antihistamine drug side effects such as decreased appetite, blurred vision, sleepiness, dry mouth, and others would hinder and further impede the market’s growth pace.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Which Region Dominated the World Antihistamines Market?

North America is projected to be to have the largest share in the United States in 2021. The dominance is brought about by an increase in allergic rhinitis cases among children. The prevalence of allergic rhinitis among children was predicted to be around 21.1% in the year 2020. Sales of nasal Antihistamines will be driven higher over the evaluation period by the rising use of nasal sprays as well as the U.S.’s well-established healthcare system. In the East Asia area, during the course of the forecast period, nasal antihistamine sales in China are anticipated to increase at a 6.5 percent CAGR. The nasal antihistamine market is expected to increase in China in the future due to rising healthcare spending per person, supportive government policies, the introduction of new products, and rising investment for life science research.

India accounted market in the year 2020. Nasal antihistamine medication is becoming more popular among the Indian Route of Administrations for the management of allergic rhinitis. Key market players can expect to have prospects for expansion when new products are introduced in the nation at relatively cheaper prices. Generic products are chosen because they are more affordable in India, where the majority of the population pays out-of-pocket for healthcare.

Segmentation of Global Antihistamines Market-

Global Antihistamines Market – By Type

Prescription-based
Over-the-counter (OTC))

Global Antihistamines Market – By Indication

Urticaria
Allergy
Dermatitis
Others

Global Antihistamines Market – By Dosage form

Tablets
Capsules
Others

Global Antihistamines Market – By Route of Administration

Oral
Parenteral
Others

Global Antihistamines Market – By End-Users

Tablets
Hospitals
Specialty Clinics
Homecare
Others

Global Antihistamines Market – By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Hospitals

Others

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Antihistamines Market

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Antihistamines Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Type
3.3.2. Dosage Form
3.3.3. Indication
3.3.4. Route of Administration
3.3.5. Geography
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Route of Administrations
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Types
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis

4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Top 6 Players
4.3. Top 3 Players
4.4. Major Strategies Adopted by Key Players

5. COVID 19 Impact Analysis
5.1. Global Antihistamines Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply

6. North America
6.1. North America Antihistamines Market, by Country, 2016-2028(US$ Bn)
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. North America Antihistamines Market, by Type, 2016-2028(US$ Bn)
6.2.1. Overview
6.2.2. Prescription-based
6.2.3. Over-the-counter (OTC))
6.2.4. Others
6.3. North America Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
6.3.1. Overview
6.3.2. Tablet
6.3.3. Capsules
6.3.4. Others
6.4. North America Antihistamines Market, by Indication, 2016-2028(US$ Bn)
6.4.1. Overview
6.4.2. Urticaria
6.4.3. Allergy
6.4.4. Dermatitis
6.4.5. Others
6.5. North America Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
6.5.1. Overview
6.5.2. Oral
6.5.3. Parenteral
6.5.4. Others
6.6. North America Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
6.6.1. Overview
6.6.2. Online
6.6.3. Direct Sales
6.6.4. Pharmacies/Drug Stores
6.6.5. Other offline channels

7. Europe
7.1. Europe Antihistamines Market, by Country, 2016-2028(US$ Bn)
7.1.1. UK
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Ukraine
7.1.7. Spain
7.1.8. Belgium
7.1.9. Netherland
7.1.10. Austria
7.1.11. Sweden
7.1.12. Poland
7.1.13. Denmark
7.1.14. Switzerland
7.1.15. Rest of Europe
7.2. Europe Antihistamines Market, by Type, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Prescription-based
7.2.3. Over-the-counter (OTC))
7.2.4. Others
7.3. Europe Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Tablet
7.3.3. Capsules
7.3.4. Others
7.4. Europe Antihistamines Market, by Indication, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Urticaria
7.4.3. Allergy
7.4.4. Dermatitis
7.4.5. Others
7.5. Europe Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
7.5.1. Overview
7.5.2. Oral
7.5.3. Parenteral
7.5.4. Others
7.6. Europe Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
7.6.1. Overview
7.6.2. Online
7.6.3. Direct Sales
7.6.4. Pharmacies/Drug Stores
7.6.5. Other offline channels

8. Asia Pacific
8.1. Asia Pacific Antihistamines Market, by Country, 2016-2028(US$ Bn)
8.1.1. China
8.1.2. Japan
8.1.3. South Korea
8.1.4. India
8.1.5. Australia
8.1.6. New Zealand
8.1.7. Taiwan
8.1.8. Indonesia
8.1.9. Malaysia
8.1.10. Philippine
8.1.11. Rest of Asia Pacific
8.2. Asia Pacific Antihistamines Market, by Type, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. Prescription-based
8.2.3. Over-the-counter (OTC))
8.2.4. Others
8.3. Asia Pacific Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. Tablet
8.3.3. Capsules
8.3.4. Others
8.4. Asia Pacific Antihistamines Market, by Indication, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. Urticaria
8.4.3. Allergy
8.4.4. Dermatitis
8.4.5. Others
8.5. Asia Pacific Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
8.5.1. Overview
8.5.2. Oral
8.5.3. Parenteral
8.5.4. Others
8.6. Asia Pacific Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
8.6.1. Overview
8.6.2. Online
8.6.3. Direct Sales
8.6.4. Pharmacies/Drug Stores
8.6.5. Other offline channels

9. Latin America
9.1. Latin America Antihistamines Market, by Country, 2016-2028(US$ Bn)
9.1.1. Brazil
9.1.2. Argentina
9.1.3. Peru
9.1.4. Chile
9.1.5. Colombia
9.1.6. Rest of Latin America
9.2. Latin America Antihistamines Market, by Type, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. Prescription-based
9.2.3. Over-the-counter (OTC))
9.2.4. Others
9.3. Latin America Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. Tablet
9.3.3. Capsules
9.3.4. Others
9.4. Latin America Antihistamines Market, by Indication, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. Urticaria
9.4.3. Allergy
9.4.4. Dermatitis
9.4.5. Others
9.5. Latin America Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
9.5.1. Overview
9.5.2. Oral
9.5.3. Parenteral
9.5.4. Others
9.6. Latin America Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
9.6.1. Overview
9.6.2. Online
9.6.3. Direct Sales
9.6.4. Pharmacies/Drug Stores
9.6.5. Other offline channels

10. Middle East
10.1. Middle East Antihistamines Market, by Country, 2016-2028(US$ Bn)
10.1.1. UAE
10.1.2. KSA
10.1.3. Israel
10.1.4. Turkey
10.1.5. Iran
10.1.6. Rest of Middle East
10.2. Middle East Antihistamines Market, by Type, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. Prescription-based
10.2.3. Over-the-counter (OTC))
10.2.4. Others
10.3. Middle East Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. Tablet
10.3.3. Capsules
10.3.4. Others
10.4. Middle East Antihistamines Market, by Indication, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. Urticaria
10.4.3. Allergy
10.4.4. Dermatitis
10.4.5. Others
10.5. Middle East Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
10.5.1. Overview
10.5.2. Oral
10.5.3. Parenteral
10.5.4. Others
10.6. Middle East Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
10.6.1. Overview
10.6.2. Online
10.6.3. Direct Sales
10.6.4. Pharmacies/Drug Stores
10.6.5. Other offline channels

11. Africa
11.1. Africa Antihistamines Market, by Country, 2016-2028(US$ Bn)
11.1.1. South Africa
11.1.2. Egypt
11.1.3. Nigeria
11.1.4. Rest of Africa
11.2. Africa Antihistamines Market, by Type, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. Prescription-based
11.2.3. Over-the-counter (OTC))
11.2.4. Others
11.3. Africa Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. Tablet
11.3.3. Capsules
11.3.4. Others
11.4. Africa Antihistamines Market, by Indication, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. Urticaria
11.4.3. Allergy
11.4.4. Dermatitis
11.4.5. Others
11.5. Africa Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
11.5.1. Overview
11.5.2. Oral
11.5.3. Parenteral
11.5.4. Others
11.6. Africa Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
11.6.1. Overview
11.6.2. Online
11.6.3. Direct Sales
11.6.4. Pharmacies/Drug Stores
11.6.5. Other offline channels

12. Global
12.1. Global Antihistamines Market, by Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. Prescription-based
12.1.3. Over-the-counter (OTC))
12.1.4. Others
12.2. Global Antihistamines Market, by Dosage Form, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. Tablet
12.2.3. Capsules
12.2.4. Others
12.3. Global Antihistamines Market, by Indication, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. Urticaria
12.3.3. Allergy
12.3.4. Dermatitis
12.3.5. Others
12.4. Global Antihistamines Market, by Route of Administration, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. Oral
12.4.3. Parenteral
12.4.4. Others
12.5. Global Antihistamines Market, by Sales Channel, 2016-2028(US$ Bn)
12.5.1. Overview
12.5.2. Online
12.5.3. Direct Sales
12.5.4. Pharmacies/Drug Stores
12.5.5. Other offline channels

13. Company Profiles
13.1. Akorn, Incorporated
13.2. Pfizer Inc.
13.3. Bristol-Myers Squibb Company
13.4. GlaxoSmithKline plc
13.5. Novartis AG
13.6. Mylan N.V.
13.7. Glenmark pharma
13.8. F. Hoffmann-La Roche Ltd.
13.9. Teva Pharmaceutical Industries Ltd.
13.10. Sanofi
13.11. Others

List of Figures

List of Figures
FIG. 1 Global Antihistamines Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Antihistamines Market Segmentation
FIG. 4 Global Antihistamines Market, by Type, 2019 (US$ Bn)
FIG. 5 Global Antihistamines Market, by Dosage Form, 2021 (US$ Bn)
FIG. 6 Global Antihistamines Market, by Geography, 2021 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2021
FIG. 8 Global Market Positioning of Key Antihistamines Market Manufacturers, 2019
FIG. 9 Global Antihistamines Market Value Contribution, By Type, 2021 & 2028 (Value %)
FIG. 10 Global Antihistamines Market, by Prescription-based, Value, 2016-2028 (US$ Bn)
FIG. 11 Global Antihistamines Market, by Over-the-counter (OTC)), Value, 2016-2028 (US$ Bn)
FIG. 12 Global Antihistamines Market Value Contribution, By Dosage Form, 2021 & 2028 (Value %)
FIG. 13 Global Antihistamines Market, by Tablet, Value, 2016-2028 (US$ Bn)
FIG. 14 Global Antihistamines Market, by Capsules, Value, 2016-2028 (US$ Bn)
FIG. 15 Global Antihistamines Market Value Contribution, By Indication, 2021 & 2028 (Value %)
FIG. 16 Global Antihistamines Market, by Urticaria, 2016-2028 (US$ Bn)
FIG. 17 Global Antihistamines Market, by Allergy, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Antihistamines Market, by Dermatitis, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Antihistamines Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Antihistamines Market Value Contribution, By Route of Administration, 2021 & 2028 (Value %)
FIG. 21 Global Antihistamines Market, by Oral, 2016-2028 (US$ Bn)
FIG. 22 Global Antihistamines Market, by Parenteral , 2016-2028 (US$ Bn)
FIG. 23 Global Antihistamines Market Value Contribution, By Sales Channel, 2021 & 2028 (Value %)
FIG. 24 Global Antihistamines Market, by Online, 2016-2028 (US$ Bn)
FIG. 25 Global Antihistamines Market, by Direct Sales, 2016-2028 (US$ Bn)
FIG. 26 Global Antihistamines Market, by Pharmacies/Drug Stores, 2016-2028 (US$ Bn)
FIG. 27 Global Antihistamines Market, by Other offline channels, 2016-2028 (US$ Bn)
FIG. 28 U.S. Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 29 Rest of North America Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 30 U.K. Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 31 Germany Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 32 France Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 33 Italy Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 34 Spain Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 35 Russia Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 36 BENELUX Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 37 Poland Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 38 Austria Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 39 Rest of Europe Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 40 Japan Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 41 China Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 42 India Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 43 South Korea Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 44 Australia Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 45 Southeast Asia Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 46 Rest of Asia Pacific Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 47 Middle East & Africa Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 48 South Africa Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 49 Nigeria Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 50 Egypt Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 51 GCC Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 52 Israel Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 53 Latin America Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 54 Mechanicalzil Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 55 Argentina Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 56 Colombia Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 57 Peru Antihistamines Market, 2016-2028 (US$ Bn)
FIG. 58 Chile Antihistamines Market, 2016-2028 (US$ Bn)

List of Tables

List of Tables
TABLE 1 Market Snapshot: Global Tablet Devices (Antihistamines ) Market
TABLE 2 Global Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 3 Global Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 4 Global Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 5 Global Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 6 Global Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 7 Global Antihistamines Market, by Geography, 2016-2028 (US$ Bn)
TABLE 8 North America Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 9 North America Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 10 North America Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 11 North America Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 12 North America Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 13 North America Antihistamines Market, by Country, 2016-2028 (US$ Bn)
TABLE 14 Europe Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 15 Europe Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 16 Europe Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 17 Europe Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 18 Europe Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 19 Europe Antihistamines Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 20 Asia Pacific Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 21 Asia Pacific Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 22 Asia Pacific Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 23 Asia Pacific Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 24 Asia Pacific Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 25 Asia Pacific Antihistamines Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 26 Latin America Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 27 Latin America Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 28 Latin America Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 29 Latin America Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 30 Latin America Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 31 Latin America Antihistamines Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 32 Middle East Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 33 Middle East Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 34 Middle East Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 35 Middle East Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 36 Middle East Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 37 Middle East Antihistamines Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 38 Africa Antihistamines Market, by Type, 2016-2028 (US$ Bn)
TABLE 39 Africa Antihistamines Market, by Dosage Form, 2016-2028 (US$ Bn)
TABLE 40 Africa Antihistamines Market, by Indication, 2016-2028 (US$ Bn)
TABLE 41 Africa Antihistamines Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 42 Africa Antihistamines Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 43 Africa Antihistamines Market, by Country/Region, 2016-2028 (US$ Bn)

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently asked questions

Which is the leading market for Antihistamines?

North America accounted for the highest share in the global Antihistamines market in terms of value as well as volume.

What are the key drivers for the growth of the Antihistamines market?

An increase in research and development activity is driving the market’s expansion. The market for antihistamine medications will benefit from these opportunities. Along with this, an increase in drug releases and approvals will speed up the market’s expansion are the major factors driving the growth of the market.

Which is the major segment in Antihistamines Market by Dosage form?

Tablets had a major share in 2021 with more than 55% of the market revenue share. Besides, capsules is projected to witness the fastest growth.

Which is the major segment in Antihistamines Market by End User?

Hospitals, industry had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Cutaneous Mastocytosis Treatment Market

The Cutaneous Mastocytosis Treatment Market size was valued at USD 210.00 million in 2018 to USD 267.00 million in 2024 and is anticipated to reach USD 536.73 million by 2032, at a CAGR of 9.21% during the forecast period.

Sinus Therapeutic Drugs Market

The Sinus Therapeutic Drugs Market is projected to grow from USD 4,595.2 million in 2024 to USD 6,192.6 million by 2032, registering a compound annual growth rate (CAGR) of 3.80% during the forecast period.

Food Allergy Treatment Market

The Food Allergy Treatment Market is projected to grow from USD 6,250 million in 2024 to USD 13,175 million by 2032, with a compound annual growth rate (CAGR) of 9.77% during the forecast period.

Vernal Keratoconjunctivitis (VKC) Market

The Vernal Keratoconjunctivitis market is projected to grow from USD 448.9 million in 2024 to USD 742.92 million by 2032, registering a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Antihistamine Drugs Market

As of 2024, the global Antihistamine Drugs Market is valued at approximately USD 94,725.5 million and is projected to expand at a compound annual growth rate (CAGR) of 6.90%, reaching around USD 161,543.15 million by 2032.

Sinusitis Treatment Drugs Market

The market for Sinusitis Treatment Drugs is projected to grow from USD 2,410 million in 2024 to USD 3,789.3 million by 2032, achieving a compound annual growth rate (CAGR) of 5.82%.

Allergic Rhinitis Drugs Market

The Allergic Rhinitis Drugs Market is projected to grow from USD 16093 million in 2024 to an estimated USD 23061.65 million by 2032, with a compound annual growth rate (CAGR) of 4.6% from 2024 to 2032.

Allergic Rhinitis Treatment Market

The global demand for Allergic Rhinitis Treatment Market was valued at USD 16,025.23 million in 2023 and to reach USD 23,375.23 million by 2032, growing at a CAGR of 3.51% between 2024 and 2032.

Pruritus Treatment Market

The global Pruritus treatment Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 4.80% between 2023 and 2030.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample